372 related articles for article (PubMed ID: 28187219)
1. Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.
Plitman E; Iwata Y; Caravaggio F; Nakajima S; Chung JK; Gerretsen P; Kim J; Takeuchi H; Chakravarty MM; Remington G; Graff-Guerrero A
Schizophr Bull; 2017 Jul; 43(4):764-777. PubMed ID: 28187219
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.
Nilsson LK; Linderholm KR; Engberg G; Paulson L; Blennow K; Lindström LH; Nordin C; Karanti A; Persson P; Erhardt S
Schizophr Res; 2005 Dec; 80(2-3):315-22. PubMed ID: 16125901
[TBL] [Abstract][Full Text] [Related]
5. Serum kynurenic acid is reduced in affective psychosis.
Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
7. Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes.
Kepplinger B; Baran H; Kainz A; Ferraz-Leite H; Newcombe J; Kalina P
Neurosignals; 2005; 14(3):126-35. PubMed ID: 16088227
[TBL] [Abstract][Full Text] [Related]
8. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
[TBL] [Abstract][Full Text] [Related]
9. Elevations of endogenous kynurenic acid produce spatial working memory deficits.
Chess AC; Simoni MK; Alling TE; Bucci DJ
Schizophr Bull; 2007 May; 33(3):797-804. PubMed ID: 16920787
[TBL] [Abstract][Full Text] [Related]
10. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.
Schwieler L; Larsson MK; Skogh E; Kegel ME; Orhan F; Abdelmoaty S; Finn A; Bhat M; Samuelsson M; Lundberg K; Dahl ML; Sellgren C; Schuppe-Koistinen I; Svensson C; Erhardt S; Engberg G
J Psychiatry Neurosci; 2015 Mar; 40(2):126-33. PubMed ID: 25455350
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine pathway in depression: A systematic review and meta-analysis.
Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993
[TBL] [Abstract][Full Text] [Related]
14. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.
Hare SM; Adhikari BM; Mo C; Chen S; Wijtenburg SA; Seneviratne C; Kane-Gerard S; Sathyasaikumar KV; Notarangelo FM; Schwarcz R; Kelly DL; Rowland LM; Buchanan RW
Neuropsychopharmacology; 2023 Oct; 48(11):1594-1601. PubMed ID: 37118058
[TBL] [Abstract][Full Text] [Related]
16. Reduction of brain kynurenic acid improves cognitive function.
Kozak R; Campbell BM; Strick CA; Horner W; Hoffmann WE; Kiss T; Chapin DS; McGinnis D; Abbott AL; Roberts BM; Fonseca K; Guanowsky V; Young DA; Seymour PA; Dounay A; Hajos M; Williams GV; Castner SA
J Neurosci; 2014 Aug; 34(32):10592-602. PubMed ID: 25100593
[TBL] [Abstract][Full Text] [Related]
17. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.
Pershing ML; Bortz DM; Pocivavsek A; Fredericks PJ; Jørgensen CV; Vunck SA; Leuner B; Schwarcz R; Bruno JP
Neuropharmacology; 2015 Mar; 90():33-41. PubMed ID: 25446576
[TBL] [Abstract][Full Text] [Related]
19. A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats.
Baratta AM; Viechweg SS; Mong JA; Pocivavsek A
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30176006
[TBL] [Abstract][Full Text] [Related]
20. Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia.
Chiappelli J; Notarangelo FM; Pocivavsek A; Thomas MAR; Rowland LM; Schwarcz R; Hong LE
Neuropsychopharmacology; 2018 Jul; 43(8):1675-1680. PubMed ID: 29520060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
